# Quality of Life Study in Participants With IPF Under Pirfenidone Treatment

> **NCT03115619** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 102 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT03115619
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-18
- **Primary completion:** 2020-01-10
- **Final completion:** 2020-01-10
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115619, "Quality of Life Study in Participants With IPF Under Pirfenidone Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03115619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*